Journal of Preventive Medicine and Public Health

The Korean Society for Preventive Medicine (대한예방의학회)
권호 표지
DOI QR코드

DOI QR Code

Lifestyle and Cancer Risk

  • Weiderpass, Elisabete (Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Departmant of Etiological Research,Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Departmant of Etiological Research, Cancer Registry of Norway, Department of Genetic Epidemiology, Folkhalsan Research Center, Department of Community Medicine, University of Tromso)
  • Published : 2010.11.30
Download PDF
⟨ Previous Next ⟩

Abstract

The main behavioural and environmental risk factors for cancer mortality in the world are related to diet and physical inactivity, use of addictive substances, sexual and reproductive health, exposure to air pollution and use of contaminated needles. The population attributable fraction for all cancer sites worldwide considering the joint effect of these factors is about 35% (34 % for low- and middle-income countries and 37% for high-income countries). Seventy-one percent of lung cancer deaths are caused by tobacco use (lung cancer is the leading cause of cancer death globally). The combined effects of tobacco use, low fruit and vegetable intake, urban air pollution, and indoor smoke from household use of solid fuels cause 76% of lung cancer deaths. Exposure to these behavioural and environmental factors is preventable; modifications in lifestyle could have a large impact in reducing the cancer burden worldwide. The evidence of association between lifestyle factors and cancer, as well as the main international recommendations for prevention are briefly reviewed and commented upon here.

Keywords

References

  1. World Health Organization. World Cancer Report 2002: Reducing Risk, Promoting Healthy Life. Geneva: World Health Organization; 2003.
  2. Danaei G, Vander Hoorn S, Lopez AD, Murray CJ, Ezzati M; Comparative Risk Assessment Collaborating Group (Cancers). Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet 2005; 366(9499): 1784-1793. https://doi.org/10.1016/S0140-6736(05)67725-2
  3. Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ; Comparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of disease. Lancet 2002; 360(9343): 1347-1360. https://doi.org/10.1016/S0140-6736(02)11403-6
  4. Ezzati M, Lopez AD, Rodgers A, Murray CJ. Comparative Quantification of Health Risks: Global and Regional Burden of Disease Attributable to Selected Major Risk Factors. Geneva: World Health Organization; 2004.
  5. World Health Organization. Global Health Risks. Mortality and Burden of Disease Attributable to Selected Major Risks. Geneva: World Health Organization; 2009.
  6. World Cancer Research Fund, American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Washington DC: AICR; 2007.
  7. Sankaranarayanan R. HPV vaccination: the promise & problems. Indian J Med Res 2009; 130(3): 322-326.
  8. Franceschi S, Cuzick J, Herrero R, Dillner J, Wheeler CM. EUROGIN 2008 roadmap on cervical cancer prevention. Int J Cancer 2009; 125(10): 2246-2255. https://doi.org/10.1002/ijc.24634
  9. Hakim AA and Dinh TA. Worldwide impact of the human papillomavirus vaccine. Curr Treat Options Oncol 2009; 10(1-2): 44-53. https://doi.org/10.1007/s11864-009-0094-4
  10. Concha-Barrientos M, Nelson DI, Driscoll T, Steenland K, Punnett L, Fingerhut MA, et al. Selected occupational risk factors. In: Ezzati M, Lopez AD, Rodgers A, Murray CJ, editors. Comparative Quantification of Health Risks: Global and Regional Burden of Disease Attributable to Selected Major Risk Factors, vol 2. Geneva: World Health Organization; 2004. P. 1651-1801.
  11. Siemiatycki J, Richardson L, Straif K , Latreille B, Lakhani R, Campbell S, et al. Listing occupational carcinogens. Environ Health Perspect 2004; 112(15): 1447-1459. https://doi.org/10.1289/ehp.7047
  12. Driscoll T, Nelson DI, Steenland K , Leigh J, Concha- Barrientos M, Fingehut M, et al. The global burden of disease due to occupational carcinogens. Am J Ind Med 2005; 48(6): 419-431. https://doi.org/10.1002/ajim.20209
  13. Kim EA, Lee HE, Kang SK. Occupational burden of cancer in Korea. Saf Health Work 2010; 1(1): 61-68. https://doi.org/10.5491/SHAW.2010.1.1.61
  14. International Agency for Research on Cancer. A Review of Human Carcinogens. Radiation. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol 100D. Lyon: IARC; in press
  15. International Agency for Research on Cancer. Tobacco Smoke and Involuntary Smoking. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol 83. Lyon: IARC; 2004.
  16. International Agency for Research on Cancer. A Review of Human Carcinogens. Lifestyle Factors. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol 100E. Lyon: IARC; in press
  17. Secretan B, Straif K, Baan R , Grosse Y, El Ghissassi F, Bouvard D, et al. A review of human carcinogens--Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol 2009; 10(11): 1033-1034. https://doi.org/10.1016/S1470-2045(09)70326-2
  18. International Agency for Research on Cancer. Hormonal Contraception and Post-menopausal Hormonal Therapy. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol 72. Lyon: IARC; 1999.
  19. International Agency for Research on Cancer. Combined Estrogen-Progestogen Contraceptives and Combined Estrogen-Progestogen Menopausal Therapy. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol 91. Lyon: IARC; 2007.
  20. International Agency for Research on Cancer. A Review of Human Carcinogens. Pharmaceuticals. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol 100A. Lyon: IARC; in press
  21. International Agency for Research on Cancer. Some Naturally Occurring Substances: Food Items and Constituents, Heterocyclic Aromatic Amines and Mycotoxins. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol 56. Lyon: IARC; 1993.
  22. International Agency for Research on Cancer. Some Traditional Herbal Medicines, Some Mycotoxins, Naphthalene and Styrene. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol 82. Lyon: IARC; 2002.
  23. International Agency for Research on Cancer. A Review of Human Carcinogens. Chemical Agents and Related Occupations. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol 100F. Lyon: IARC; in press
  24. International Agency for Research on Cancer. Schistosomes, Liver Flukes and Helicobacter Pylori. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol 61. Lyon: IARC; 1994.
  25. International Agency for Research on Cancer. A Review of Human Carcinogens. Biological Agents. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol 100B. Lyon: IARC; in press.
  26. International Agency for Research on Cancer. Human Immunodeficiency Viruses and Human T-Cell Lymphotropic Viruses. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol 67. Lyon: IARC; 1996.
  27. World Health Organization. WHO fact sheets. Western Pacific Region. 2002 May [cited 2010 Nov 2]. Available from: http://www.wpro.who.int/media_centre/fact_sheets/fs_20020528.htm.
  28. World Health Organization. WHO framework convention on tobacco control. WHO library cataloguing-inpublication data. 2005 [cited 2010 Nov 2]. Available from: http://www.who.int/fctc/en/.
  29. World Cancer Research Fund. WCRF policy report. 2007 [cited 2010 Oct 31]. Available from: http://www.wcrfuk.org/research/cp_policy_report.php.

Cited by

  1. Down-regulation of UHRF1, associated with re-expression of tumor suppressor genes, is a common feature of natural compounds exhibiting anti-cancer properties vol.30, pp.1, 2010, https://doi.org/10.1186/1756-9966-30-41
  2. Preventable Lifestyle Risk Factors for Non-Communicable Diseases in the Pakistan Adolescents Schools Study 1 (PASS-1) vol.44, pp.5, 2011, https://doi.org/10.3961/jpmph.2011.44.5.210
  3. Azadirachta indica exhibits chemopreventive action against hepatic cancer: Studies on associated histopathological and ultrastructural changes vol.75, pp.5, 2010, https://doi.org/10.1002/jemt.21095
  4. F box protein FBXL2 exerts human lung tumor suppressor-like activity by ubiquitin-mediated degradation of cyclin D3 resulting in cell cycle arrest vol.31, pp.20, 2012, https://doi.org/10.1038/onc.2011.432
  5. Preventie: waar mankeert het aan? vol.90, pp.7, 2010, https://doi.org/10.1007/s12508-012-0137-2
  6. Dietary Intake Measured from a Self-Administered, Online 24-Hour Recall System Compared with 4-Day Diet Records in an Adult US Population vol.112, pp.10, 2010, https://doi.org/10.1016/j.jand.2012.06.003
  7. Spectroscopic Characterization of Lycopene Extract from Lycopersicum esculentum (Tomato) and Its Evaluation as a Chemopreventive Agent Against Experimental Hepatocarcinogenesis in Mice vol.27, pp.3, 2010, https://doi.org/10.1002/ptr.4741
  8. Edible Insects in a Food Safety and Nutritional Perspective: A Critical Review vol.12, pp.3, 2010, https://doi.org/10.1111/1541-4337.12014
  9. Feasibility of a Multdisciplinary Lung Cancer Videoconference between a Peripheral Hospital and a Comprehensive Cancer Centre vol.84, pp.3, 2010, https://doi.org/10.1159/000345314
  10. Präventionspotenziale für Darm- und Brustkrebs in Deutschland : Eine methodische Evaluation von Schätzungen für die Risikofaktoren Alkohol und Übergewicht vol.56, pp.3, 2010, https://doi.org/10.1007/s00103-012-1625-x
  11. Second primary malignancies in head and neck cancer patients : High prevalence of curable-stage disease vol.189, pp.10, 2010, https://doi.org/10.1007/s00066-013-0404-4
  12. Antioxidant effect of lycopene-enriched tomato paste on N -nitrosodiethylamine-induced oxidative stress in rats vol.70, pp.4, 2014, https://doi.org/10.1007/s13105-014-0367-7
  13. Positive association between lymphotoxin-alpha variation rs909253 and cancer risk: a meta-analysis based on 36 case-control studies vol.35, pp.3, 2010, https://doi.org/10.1007/s13277-013-1263-4
  14. Consumer Intentions to Buy Front-of-Pack Nutrition Labeled Food Products: The Moderating Effects of Personality Differences vol.20, pp.4, 2010, https://doi.org/10.1080/10454446.2013.807409
  15. Lowered Cancer Risk With ACE Inhibitors/ARBs: A Population-Based Cohort Study vol.16, pp.1, 2010, https://doi.org/10.1111/jch.12228
  16. Positive Association Between IL-16 rs11556218 T/G Polymorphism and Cancer Risk: a Meta-analysis vol.15, pp.11, 2014, https://doi.org/10.7314/apjcp.2014.15.11.4697
  17. Association of Changes in Fitness and Body Composition with Cancer Mortality in Men vol.46, pp.7, 2014, https://doi.org/10.1249/mss.0000000000000225
  18. Tobacco, Alcohol, and Cancer in Low and High Income Countries vol.80, pp.5, 2010, https://doi.org/10.1016/j.aogh.2014.09.010
  19. Polycyclic aromatic hydrocarbons and PAH-related DNA adducts vol.58, pp.3, 2010, https://doi.org/10.1007/s13353-016-0380-3
  20. Prevalence, Pattern, and Correlates of Alcohol Misuse among Male Patients Attending Rural Primary Care in India vol.9, pp.1, 2010, https://doi.org/10.4103/jpbs.jpbs_325_16
  21. Tackling the tobacco epidemic in the Nordic countries and lower cancer incidence by 1/5 in a 30-year period—The effect of envisaged scenarios changing smoking prevalence vol.103, pp.None, 2010, https://doi.org/10.1016/j.ejca.2018.02.031
  22. Plants Used as Anticancer Agents in the Ethiopian Traditional Medical Practices: A Systematic Review vol.2018, pp.None, 2010, https://doi.org/10.1155/2018/6274021
  23. Diet and cancer prevention: Dietary compounds, dietary MicroRNAs, and dietary exosomes vol.119, pp.1, 2010, https://doi.org/10.1002/jcb.26244
  24. The influence of environmental constraints within hospitals on physical activity level of cancer patients vol.14, pp.3, 2010, https://doi.org/10.12965/jer.1836240.120
  25. Bioenergetics of life, disease and death phenomena vol.137, pp.2, 2010, https://doi.org/10.1007/s12064-018-0266-5
  26. Raising Awareness for Lung Cancer Prevention and Healthy Lifestyles in Female Scholars from a Low-Income Area in Bogota, Colombia: Evaluation of a National Framework vol.33, pp.6, 2010, https://doi.org/10.1007/s13187-017-1246-z
  27. Effects of Exergaming on Quality of Life in Cancer Patients vol.7, pp.6, 2010, https://doi.org/10.1089/g4h.2017.0174
  28. Antioxidant supplementation and breast cancer prognosis in postmenopausal women undergoing chemotherapy and radiation therapy vol.109, pp.1, 2010, https://doi.org/10.1093/ajcn/nqy223
  29. Körperliche Aktivität in der Krebsprimärprävention vol.34, pp.1, 2019, https://doi.org/10.1007/s12312-018-0528-7
  30. Potential of Zerumbone as an Anti-Cancer Agent vol.24, pp.4, 2010, https://doi.org/10.3390/molecules24040734
  31. Lung Cancers and the Roles of Natural Compounds as Potential Chemotherapeutic and Chemopreventive Agents vol.12, pp.1, 2019, https://doi.org/10.13005/bpj/1617
  32. A Linkage Between Thyroid and Breast Cancer: A Common Etiology? vol.28, pp.4, 2010, https://doi.org/10.1158/1055-9965.epi-18-0877
  33. The overall and sex- and age-group specific incidence rates of cancer in people with schizophrenia: a population-based cohort study vol.29, pp.None, 2010, https://doi.org/10.1017/s204579602000044x
  34. Addictions Causing Head-and-Neck Cancers vol.41, pp.4, 2010, https://doi.org/10.4103/ijmpo.ijmpo_99_20
  35. An Overview of the Potential Antineoplastic Effects of Casticin vol.25, pp.6, 2020, https://doi.org/10.3390/molecules25061287
  36. In silico analyzing the molecular interactions of plant-derived inhibitors against E6AP, p53, and c-Myc binding sites of HPV type 16 E6 oncoprotein vol.9, pp.2, 2010, https://doi.org/10.22099/mbrc.2020.36522.1483
  37. The influence of lifestyle factors on miRNA expression and signal pathways: a review vol.13, pp.2, 2010, https://doi.org/10.2217/epi-2020-0289
  38. Combined Lifestyle Behaviors and the Incidence of Common Cancer Types in the Norwegian Women and Cancer Study (NOWAC) vol.13, pp.None, 2010, https://doi.org/10.2147/clep.s312864
  39. Low Blood-As Levels and Selected Genotypes Appears to Be Promising Biomarkers for Occurrence of Colorectal Cancer in Women vol.9, pp.9, 2021, https://doi.org/10.3390/biomedicines9091105